APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Medical Device Software Validation

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Medical Device Software Validation Market Outlook and Growth Opportunities 2026

Report ID 17418520045 June 2026208 pages

Choose your research edition.

Industry ResearchMedical Device Software Validation Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Device Software Validation Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Medical Device Software Validation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Device Software Validation Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Device Software Validation Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Medical Device Software Validation market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Medical Device Software Validation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Medical Device Software Validation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medical Device Software Validation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Medical Device Software Validation market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Medical Device Software Validation market include QbD Group, Intertek, SGS, QuEST, TÜV SÜD AG, NAMSA, Element, Eurofins Scientific and Charles River, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Medical Device Software Validation market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Medical Device Software Validation and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medical Device Software Validation revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Medical Device Software Validation market.

Medical Device Software Validation Segment by Company

QbD Group

Intertek

SGS

QuEST

TÜV SÜD AG

NAMSA

Element

Eurofins Scientific

Charles River

Sterling Medical Devices

Pacific Biolabs

Toxikon

Steris Laboratories

Europlaz Technologies

Tata Elxsi

Onyx Healthcare

Medical Device Software Validation Segment by Type

Unit Testing

Integration Testing

System Testing

Others

Medical Device Software Validation Segment by Application

Medical Device Manufacturing

Pharmaceutical

Biotechnology

Research and Development

Medical Device Software Validation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Medical Device Software Validation status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Medical Device Software Validation key companies, revenue, market share, and recent developments.

3. To split the Medical Device Software Validation breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Medical Device Software Validation market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Medical Device Software Validation significant trends, drivers, influence factors in global and regions.

6. To analyze Medical Device Software Validation competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Device Software Validation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Device Software Validation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Device Software Validation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Device Software Validation industry.

Chapter 3: Detailed analysis of Medical Device Software Validation company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Medical Device Software Validation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Medical Device Software Validation in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Medical Device Software Validation Industry Trends Table 2. Medical Device Software Validation Industry Drivers Table 3. Medical Device Software Validation Industry Opportunities and Challenges Table 4. Medical Device Software Validation Industry Restraints Table 5. Global Medical Device Software Validation Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Medical Device Software Validation Revenue Share by Company (2021-2026) Table 7. Global Medical Device Software Validation Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Medical Device Software Validation Key Company Manufacturing Base & Headquarters Table 9. Global Medical Device Software Validation Company, Product Type & Application Table 10. Global Medical Device Software Validation Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Medical Device Software Validation by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Unit Testing Table 15. Significant Companies of Integration Testing Table 16. Significant Companies of System Testing Table 17. Significant Companies of Others Table 18. Global Medical Device Software Validation Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Medical Device Software Validation Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Medical Device Software Validation Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Medical Device Software Validation Sales Value Share by Type (2021-2026) Table 22. Global Medical Device Software Validation Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Medical Device Manufacturing Table 24. Significant Companies of Pharmaceutical Table 25. Significant Companies of Biotechnology Table 26. Significant Companies of Research and Development Table 27. Global Medical Device Software Validation Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Medical Device Software Validation Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Medical Device Software Validation Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Medical Device Software Validation Sales Value Share by Application (2021-2026) Table 31. Global Medical Device Software Validation Sales Value Share by Application (2027-2032) Table 32. Global Medical Device Software Validation Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Medical Device Software Validation Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Medical Device Software Validation Sales Value Share by Region (2021-2026) Table 35. Global Medical Device Software Validation Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Medical Device Software Validation Sales Value Share by Region (2027-2032) Table 37. Global Medical Device Software Validation Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Medical Device Software Validation Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Medical Device Software Validation Sales Value Market Share by Country (2021-2026) Table 40. Global Medical Device Software Validation Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Medical Device Software Validation Sales Value Market Share by Country (2027-2032) Table 42. QbD Group Company Information Table 43. QbD Group Business Overview Table 44. QbD Group Medical Device Software Validation Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. QbD Group Medical Device Software Validation Product Portfolio Table 46. QbD Group Recent Development Table 47. Intertek Company Information Table 48. Intertek Business Overview Table 49. Intertek Medical Device Software Validation Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Intertek Medical Device Software Validation Product Portfolio Table 51. Intertek Recent Development Table 52. SGS Company Information Table 53. SGS Business Overview Table 54. SGS Medical Device Software Validation Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. SGS Medical Device Software Validation Product Portfolio Table 56. SGS Recent Development Table 57. QuEST Company Information Table 58. QuEST Business Overview Table 59. QuEST Medical Device Software Validation Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. QuEST Medical Device Software Validation Product Portfolio Table 61. QuEST Recent Development Table 62. TÜV SÜD AG Company Information Table 63. TÜV SÜD AG Business Overview Table 64. TÜV SÜD AG Medical Device Software Validation Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. TÜV SÜD AG Medical Device Software Validation Product Portfolio Table 66. TÜV SÜD AG Recent Development Table 67. NAMSA Company Information Table 68. NAMSA Business Overview Table 69. NAMSA Medical Device Software Validation Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. NAMSA Medical Device Software Validation Product Portfolio Table 71. NAMSA Recent Development Table 72. Element Company Information Table 73. Element Business Overview Table 74. Element Medical Device Software Validation Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Element Medical Device Software Validation Product Portfolio Table 76. Element Recent Development Table 77. Eurofins Scientific Company Information Table 78. Eurofins Scientific Business Overview Table 79. Eurofins Scientific Medical Device Software Validation Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Eurofins Scientific Medical Device Software Validation Product Portfolio Table 81. Eurofins Scientific Recent Development Table 82. Charles River Company Information Table 83. Charles River Business Overview Table 84. Charles River Medical Device Software Validation Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Charles River Medical Device Software Validation Product Portfolio Table 86. Charles River Recent Development Table 87. Sterling Medical Devices Company Information Table 88. Sterling Medical Devices Business Overview Table 89. Sterling Medical Devices Medical Device Software Validation Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Sterling Medical Devices Medical Device Software Validation Product Portfolio Table 91. Sterling Medical Devices Recent Development Table 92. Pacific Biolabs Company Information Table 93. Pacific Biolabs Business Overview Table 94. Pacific Biolabs Medical Device Software Validation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Pacific Biolabs Medical Device Software Validation Product Portfolio Table 96. Pacific Biolabs Recent Development Table 97. Toxikon Company Information Table 98. Toxikon Business Overview Table 99. Toxikon Medical Device Software Validation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Toxikon Medical Device Software Validation Product Portfolio Table 101. Toxikon Recent Development Table 102. Steris Laboratories Company Information Table 103. Steris Laboratories Business Overview Table 104. Steris Laboratories Medical Device Software Validation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Steris Laboratories Medical Device Software Validation Product Portfolio Table 106. Steris Laboratories Recent Development Table 107. Europlaz Technologies Company Information Table 108. Europlaz Technologies Business Overview Table 109. Europlaz Technologies Medical Device Software Validation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Europlaz Technologies Medical Device Software Validation Product Portfolio Table 111. Europlaz Technologies Recent Development Table 112. Tata Elxsi Company Information Table 113. Tata Elxsi Business Overview Table 114. Tata Elxsi Medical Device Software Validation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Tata Elxsi Medical Device Software Validation Product Portfolio Table 116. Tata Elxsi Recent Development Table 117. Onyx Healthcare Company Information Table 118. Onyx Healthcare Business Overview Table 119. Onyx Healthcare Medical Device Software Validation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Onyx Healthcare Medical Device Software Validation Product Portfolio Table 121. Onyx Healthcare Recent Development Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Medical Device Software Validation Product Image Figure 2. Global Medical Device Software Validation Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Device Software Validation Market Size (2021-2032) & (US$ Million) Figure 4. Global Medical Device Software Validation Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Unit Testing Image Figure 8. Integration Testing Image Figure 9. System Testing Image Figure 10. Others Image Figure 11. Global Medical Device Software Validation Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Medical Device Software Validation Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Medical Device Software Validation Sales Value Share by Type (2021-2032) Figure 14. Medical Device Manufacturing Image Figure 15. Pharmaceutical Image Figure 16. Biotechnology Image Figure 17. Research and Development Image Figure 18. Global Medical Device Software Validation Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Medical Device Software Validation Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Medical Device Software Validation Sales Value Share by Application (2021-2032) Figure 21. Global Medical Device Software Validation Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Medical Device Software Validation Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Medical Device Software Validation Sales Value (2021-2032) & (US$ Million) Figure 24. North America Medical Device Software Validation Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Medical Device Software Validation Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Medical Device Software Validation Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Medical Device Software Validation Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Medical Device Software Validation Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Medical Device Software Validation Sales Value (2021-2032) & (US$ Million) Figure 30. South America Medical Device Software Validation Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Medical Device Software Validation Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Medical Device Software Validation Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Medical Device Software Validation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Medical Device Software Validation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Medical Device Software Validation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Medical Device Software Validation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Medical Device Software Validation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Medical Device Software Validation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Medical Device Software Validation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Medical Device Software Validation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Medical Device Software Validation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Medical Device Software Validation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Medical Device Software Validation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Medical Device Software Validation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Medical Device Software Validation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Medical Device Software Validation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Medical Device Software Validation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Medical Device Software Validation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Medical Device Software Validation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Medical Device Software Validation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Medical Device Software Validation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Medical Device Software Validation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Medical Device Software Validation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Medical Device Software Validation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Medical Device Software Validation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Medical Device Software Validation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Medical Device Software Validation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Medical Device Software Validation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Medical Device Software Validation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Medical Device Software Validation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Unit Testing
  • Integration Testing
  • System Testing
  • Others
Applications
  • Medical Device Manufacturing
  • Pharmaceutical
  • Biotechnology
  • Research and Development
Companies covered
  • QbD Group
  • Intertek
  • SGS
  • QuEST
  • TÜV SÜD AG
  • NAMSA
  • Element
  • Eurofins Scientific
  • Charles River
  • Sterling Medical Devices
  • Pacific Biolabs
  • Toxikon
  • Steris Laboratories
  • Europlaz Technologies
  • Tata Elxsi
  • Onyx Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Medical Device Software Validation Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Medical Device Software Validation Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Medical Device Software Validation Market Dynamics
  1. 2.1 Medical Device Software Validation Industry Trends
  2. 2.2 Medical Device Software Validation Industry Drivers
  3. 2.3 Medical Device Software Validation Industry Opportunities and Challenges
  4. 2.4 Medical Device Software Validation Industry Restraints
3 Medical Device Software Validation Market by Company
  1. 3.1 Global Medical Device Software Validation Company Revenue Ranking in 2025
  2. 3.2 Global Medical Device Software Validation Revenue by Company (2021-2026)
  3. 3.3 Global Medical Device Software Validation Company Ranking (2024-2026)
  4. 3.4 Global Medical Device Software Validation Company Manufacturing Base and Headquarters
  5. 3.5 Global Medical Device Software Validation Company Product Type and Application
  6. 3.6 Global Medical Device Software Validation Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Medical Device Software Validation Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Medical Device Software Validation Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Medical Device Software Validation Market by Type
  1. 4.1 Medical Device Software Validation Type Introduction
  2. 4.1.1 Unit Testing
  3. 4.1.2 Integration Testing
  4. 4.1.3 System Testing
  5. 4.1.4 Others
  6. 4.2 Global Medical Device Software Validation Sales Value by Type
  7. 4.2.1 Global Medical Device Software Validation Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Medical Device Software Validation Sales Value by Type (2021-2032)
  9. 4.2.3 Global Medical Device Software Validation Sales Value Share by Type (2021-2032)
5 Medical Device Software Validation Market by Application
  1. 5.1 Medical Device Software Validation Application Introduction
  2. 5.1.1 Medical Device Manufacturing
  3. 5.1.2 Pharmaceutical
  4. 5.1.3 Biotechnology
  5. 5.1.4 Research and Development
  6. 5.2 Global Medical Device Software Validation Sales Value by Application
  7. 5.2.1 Global Medical Device Software Validation Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Medical Device Software Validation Sales Value by Application (2021-2032)
  9. 5.2.3 Global Medical Device Software Validation Sales Value Share by Application (2021-2032)
6 Medical Device Software Validation Regional Value Analysis
  1. 6.1 Global Medical Device Software Validation Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Medical Device Software Validation Sales Value by Region (2021-2032)
  3. 6.2.1 Global Medical Device Software Validation Sales Value by Region: 2021-2026
  4. 6.2.2 Global Medical Device Software Validation Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Medical Device Software Validation Sales Value (2021-2032)
  7. 6.3.2 North America Medical Device Software Validation Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Medical Device Software Validation Sales Value (2021-2032)
  10. 6.4.2 Europe Medical Device Software Validation Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Medical Device Software Validation Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Medical Device Software Validation Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Medical Device Software Validation Sales Value (2021-2032)
  16. 6.6.2 South America Medical Device Software Validation Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Medical Device Software Validation Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Medical Device Software Validation Sales Value Share by Country, 2025 VS 2032
7 Medical Device Software Validation Country-level Value Analysis
  1. 7.1 Global Medical Device Software Validation Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Medical Device Software Validation Sales Value by Country (2021-2032)
  3. 7.2.1 Global Medical Device Software Validation Sales Value by Country (2021-2026)
  4. 7.2.2 Global Medical Device Software Validation Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Medical Device Software Validation Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Medical Device Software Validation Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Medical Device Software Validation Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Medical Device Software Validation Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Medical Device Software Validation Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Medical Device Software Validation Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Medical Device Software Validation Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Medical Device Software Validation Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Medical Device Software Validation Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Medical Device Software Validation Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Medical Device Software Validation Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Medical Device Software Validation Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Medical Device Software Validation Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Medical Device Software Validation Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Medical Device Software Validation Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Medical Device Software Validation Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Medical Device Software Validation Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Medical Device Software Validation Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Medical Device Software Validation Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Medical Device Software Validation Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Medical Device Software Validation Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Medical Device Software Validation Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Medical Device Software Validation Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Medical Device Software Validation Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Medical Device Software Validation Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Medical Device Software Validation Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Medical Device Software Validation Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Medical Device Software Validation Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Medical Device Software Validation Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Medical Device Software Validation Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 QbD Group
  2. 8.1.1 QbD Group Company Information
  3. 8.1.2 QbD Group Business Overview
  4. 8.1.3 QbD Group Medical Device Software Validation Revenue and Gross Margin (2021-2026)
  5. 8.1.4 QbD Group Medical Device Software Validation Product Portfolio
  6. 8.1.5 QbD Group Recent Developments
  7. 8.2 Intertek
  8. 8.2.1 Intertek Company Information
  9. 8.2.2 Intertek Business Overview
  10. 8.2.3 Intertek Medical Device Software Validation Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Intertek Medical Device Software Validation Product Portfolio
  12. 8.2.5 Intertek Recent Developments
  13. 8.3 SGS
  14. 8.3.1 SGS Company Information
  15. 8.3.2 SGS Business Overview
  16. 8.3.3 SGS Medical Device Software Validation Revenue and Gross Margin (2021-2026)
  17. 8.3.4 SGS Medical Device Software Validation Product Portfolio
  18. 8.3.5 SGS Recent Developments
  19. 8.4 QuEST
  20. 8.4.1 QuEST Company Information
  21. 8.4.2 QuEST Business Overview
  22. 8.4.3 QuEST Medical Device Software Validation Revenue and Gross Margin (2021-2026)
  23. 8.4.4 QuEST Medical Device Software Validation Product Portfolio
  24. 8.4.5 QuEST Recent Developments
  25. 8.5 TÜV SÜD AG
  26. 8.5.1 TÜV SÜD AG Company Information
  27. 8.5.2 TÜV SÜD AG Business Overview
  28. 8.5.3 TÜV SÜD AG Medical Device Software Validation Revenue and Gross Margin (2021-2026)
  29. 8.5.4 TÜV SÜD AG Medical Device Software Validation Product Portfolio
  30. 8.5.5 TÜV SÜD AG Recent Developments
  31. 8.6 NAMSA
  32. 8.6.1 NAMSA Company Information
  33. 8.6.2 NAMSA Business Overview
  34. 8.6.3 NAMSA Medical Device Software Validation Revenue and Gross Margin (2021-2026)
  35. 8.6.4 NAMSA Medical Device Software Validation Product Portfolio
  36. 8.6.5 NAMSA Recent Developments
  37. 8.7 Element
  38. 8.7.1 Element Company Information
  39. 8.7.2 Element Business Overview
  40. 8.7.3 Element Medical Device Software Validation Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Element Medical Device Software Validation Product Portfolio
  42. 8.7.5 Element Recent Developments
  43. 8.8 Eurofins Scientific
  44. 8.8.1 Eurofins Scientific Company Information
  45. 8.8.2 Eurofins Scientific Business Overview
  46. 8.8.3 Eurofins Scientific Medical Device Software Validation Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Eurofins Scientific Medical Device Software Validation Product Portfolio
  48. 8.8.5 Eurofins Scientific Recent Developments
  49. 8.9 Charles River
  50. 8.9.1 Charles River Company Information
  51. 8.9.2 Charles River Business Overview
  52. 8.9.3 Charles River Medical Device Software Validation Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Charles River Medical Device Software Validation Product Portfolio
  54. 8.9.5 Charles River Recent Developments
  55. 8.10 Sterling Medical Devices
  56. 8.10.1 Sterling Medical Devices Company Information
  57. 8.10.2 Sterling Medical Devices Business Overview
  58. 8.10.3 Sterling Medical Devices Medical Device Software Validation Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sterling Medical Devices Medical Device Software Validation Product Portfolio
  60. 8.10.5 Sterling Medical Devices Recent Developments
  61. 8.11 Pacific Biolabs
  62. 8.11.1 Pacific Biolabs Company Information
  63. 8.11.2 Pacific Biolabs Business Overview
  64. 8.11.3 Pacific Biolabs Medical Device Software Validation Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Pacific Biolabs Medical Device Software Validation Product Portfolio
  66. 8.11.5 Pacific Biolabs Recent Developments
  67. 8.12 Toxikon
  68. 8.12.1 Toxikon Company Information
  69. 8.12.2 Toxikon Business Overview
  70. 8.12.3 Toxikon Medical Device Software Validation Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Toxikon Medical Device Software Validation Product Portfolio
  72. 8.12.5 Toxikon Recent Developments
  73. 8.13 Steris Laboratories
  74. 8.13.1 Steris Laboratories Company Information
  75. 8.13.2 Steris Laboratories Business Overview
  76. 8.13.3 Steris Laboratories Medical Device Software Validation Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Steris Laboratories Medical Device Software Validation Product Portfolio
  78. 8.13.5 Steris Laboratories Recent Developments
  79. 8.14 Europlaz Technologies
  80. 8.14.1 Europlaz Technologies Company Information
  81. 8.14.2 Europlaz Technologies Business Overview
  82. 8.14.3 Europlaz Technologies Medical Device Software Validation Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Europlaz Technologies Medical Device Software Validation Product Portfolio
  84. 8.14.5 Europlaz Technologies Recent Developments
  85. 8.15 Tata Elxsi
  86. 8.15.1 Tata Elxsi Company Information
  87. 8.15.2 Tata Elxsi Business Overview
  88. 8.15.3 Tata Elxsi Medical Device Software Validation Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Tata Elxsi Medical Device Software Validation Product Portfolio
  90. 8.15.5 Tata Elxsi Recent Developments
  91. 8.16 Onyx Healthcare
  92. 8.16.1 Onyx Healthcare Company Information
  93. 8.16.2 Onyx Healthcare Business Overview
  94. 8.16.3 Onyx Healthcare Medical Device Software Validation Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Onyx Healthcare Medical Device Software Validation Product Portfolio
  96. 8.16.5 Onyx Healthcare Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst